Exercises Using Virtual Reality on Cancer Patients

January 5, 2025 updated by: Ahmed Abdelmoniem Ibrahim, University of Hail

Effectiveness of Virtual Reality Using Pablo Game Training Program on Upper Extremity Muscle Strength, Pain, Function and Activity of Daily Living in Post-operative Breast Cancer Female Patients.

in this study, a randomized controlled trial will be conducted to evaluate the effect of adding exercises using virtual reality on achievements in patients having breast cancer and conducted surgical treatment

Study Overview

Status

Completed

Detailed Description

in this study, a randomized controlled trial will be conducted to evaluate the effect of adding exercises using virtual reality on achievements in patients having breast cancer and conducted surgical treatment.

A virtual reality (VR) environment is created by combining computer systems and sensor technology with the use of three-dimensional graphics and enabling users to experience a more real, immersive experience by utilizing their various senses (vision, hearing, touch, etc.) through the use of the computer and sensor technologies and it is characterized by immersion, imagination, and interaction 2 groups will be selected randomly to receive experimental and control intervention for 1 month and outcomes will be collected before and after treatment.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Breast cancer female patients
  • Age ≥40 years
  • All patients with Eastern Cooperative Oncology Group performance status score ≤ 2
  • Having to undergo primary treatment with surgery, chemotherapy, and/or radiotherapy based on the patient's need

Exclusion Criteria:

  • Severe anemia (Hb ≤ 8 g/dL)
  • Uncontrolled hypertension, diabetes
  • severe infection, neurologic or muscular diseases prohibiting physical activity
  • severe heart disease or myocardial infarction during the last six months, and a severe chronic obstructive pulmonary disease
  • uncontrolled and/or extensive brain metastases, or bone metastases that were assessed to pose a risk of pathological fractures from exercising
  • Contraindications given by the physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: virtual reality

The patients in this group are under exercise training and pneumatic pressure followed by Pablo©Handle training for 45 minutes per week for 8 week

-Pablo©Handle training One-dimensional therapy games using five games are available for Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Apple hunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week

this is a one-dimensional therapy game using (Handle/ or Multiball) five games are available for the Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Applehunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week
Other Names:
  • Pablo©Handle training
Active Comparator: regular exercises

The patients in this group will receive exercise training and pneumatic pressure only for 30 min3 times per week for 8 week

  • Exercise training will be done by the following exercise for 15 min3 times per week for 8 week
  • Intermittent Compression Therapy Parameters: using the (Care Pump expert 8)
  • Pressure. 60 mmHg, Direction. Distal to proximal, Speed 4 to 5, for 15 min /3 times per week for 8 week
this is a one-dimensional therapy game using (Handle/ or Multiball) five games are available for the Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Applehunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week
Other Names:
  • Pablo©Handle training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handgrip strength
Time Frame: at baseline
will be measured by Pablo system for the affected and unaffected upper limbs
at baseline
handgrip strength
Time Frame: after the end of the treatment (after 8 weeks)
will be measured by Pablo system for the affected and unaffected upper limbs
after the end of the treatment (after 8 weeks)
wrist joint active range of motion (ROM)
Time Frame: baseline
flexion and extension active ROM of the wrist joints will be assessed using Pablo system
baseline
wrist joint active ROM
Time Frame: after the end of the treatment (after 8 weeks)
flexion and extension active ROM of the wrist joints will be assessed using Pablo system
after the end of the treatment (after 8 weeks)
Disabilities of the Arm, Shoulder and Hand (DASH)
Time Frame: at baseline
DASH is a 30-item questionnaire. Each item is scored on a 1 (no difficulty) to 5 (unable) scale. The total score may range from 0 to 100 points. High scores indicate a high level of disability.
at baseline
Disabilities of the Arm, Shoulder and Hand (DASH)
Time Frame: after the end of the treatment (after 8 weeks)
DASH is a 30-item questionnaire. Each item is scored on a 1 (no difficulty) to 5 (unable) scale. The total score may range from 0 to 100 points. High scores indicate a high level of disability.
after the end of the treatment (after 8 weeks)
Fatigue by Multidimensional Fatigue Inventory
Time Frame: at baseline
The MFI is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue.
at baseline
Fatigue by Multidimensional Fatigue Inventory
Time Frame: after the end of the treatment (after 8 weeks)
The MFI is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue.
after the end of the treatment (after 8 weeks)
Anxiety by The State Anxiety Inventory (SAI)
Time Frame: at baseline
SAI is a valid and commonly used measure for anxiety The SAI includes 20 items; each item is scored on a 4-point Likert scale The SAI range of total scores is between 20 and 80, with the higher score indicating more anxiety
at baseline
Anxiety by The State Anxiety Inventory (SAI)
Time Frame: after the end of the treatment (after 8 weeks)
SAI is a valid and commonly used measure for anxiety The SAI includes 20 items; each item is scored on a 4-point Likert scale The SAI range of total scores is between 20 and 80, with the higher score indicating more anxiety
after the end of the treatment (after 8 weeks)
Pain using Numerical Rating Scale (NRS)
Time Frame: at baseline
this scale is valid and reliable measure of pain intensity. the patient is asked to rate pain intensity be choosing a number from 0 to 10 where 0 indicates no pain and 10 indicates the worst pain ever
at baseline
Pain using Numerical Rating Scale (NRS)
Time Frame: after the end of the treatment (after 8 weeks)
this scale is valid and reliable measure of pain intensity. the patient is asked to rate pain intensity be choosing a number from 0 to 10 where 0 indicates no pain and 10 indicates the worst pain ever
after the end of the treatment (after 8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2023

Primary Completion (Actual)

June 12, 2024

Study Completion (Actual)

July 30, 2024

Study Registration Dates

First Submitted

September 21, 2023

First Submitted That Met QC Criteria

September 21, 2023

First Posted (Actual)

September 28, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 5, 2025

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • H-2023-366

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe